Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal vs Intravenous Ipilimumab + Nivolumab in Advanced Melanoma
NCT07615881Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2026
- Primary completion
- Jul 2028
01
Overview
A Phase 2 trial of ipilimumab in melanoma, sponsored by Amsterdam University Medical Center. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
ipilimumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT07615881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07615881.